Biotechnology News

October 1, 2014

BRISBANE, Australia--(BUSINESS WIRE)--iMDsoft will be presenting MetaVision Anaesthesia, our advanced Anaesthesia Information Management System, at ASA NSC in Gold Coast from the 4th to 7th October.

October 1, 2014

YOKOHAMA, Japan--(BUSINESS WIRE)--Business Wire is the official media partner for the BioJapan 2014. Breaking news releases, online press kits are available at Tradeshownews.com.

October 1, 2014

WASHINGTON--(BUSINESS WIRE)--The lack of context in CMS’s Sunshine data threatens health care innovation.

October 1, 2014

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD granted two new patents

October 1, 2014

NEW YORK--(BUSINESS WIRE)--Retrophin, Inc. (NASDAQ:RTRX) today announced a leadership reorganization under which the Board of Directors has appointed Stephen Aselage as interim Chief Executive Officer (CEO), effective immediately, to replace...

October 1, 2014

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb to Transfer $1.4 Billion in U.S. Pension Obligations to Prudential

October 1, 2014

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Project Xenon Press Release - September 30, 2014

October 1, 2014

BEDMINSTER, N.J. & RESEARCH TRIANGLE PARK, N.C. & NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of...

September 30, 2014

ROCHESTER, N.Y.--(BUSINESS WIRE)--ACM Medical Laboratory’s VP of Scientific Affairs and Laboratory Operations Continues her Role as Senior Editor to Update Leading Laboratory Testing Textbook for Global Provider Community

September 30, 2014

PARIS--(BUSINESS WIRE)--Cellectis: First-half 2014 financial results

A successful therapeutic focus
A drastic reduction of its operating expenses

September 30, 2014

LYON, France--(BUSINESS WIRE)--Regulatory News: ERYTECH  (Paris:ERYP) (Euronext Paris: FR0011471135 - ERYP), the French biopharmaceutical company that develops innovative ‘tumor starvation’ treatments for acute leukemia and other oncology...

September 30, 2014

ROCKVILLE, Md.--(BUSINESS WIRE)--KAI Research, Inc. (KAI), a wholly owned subsidiary of Altarum Institute, announced today that the Centers for Disease Control and Prevention (CDC) awarded it a contract to evaluate samples of pediatric, adult,...

September 30, 2014

WASHINGTON--(BUSINESS WIRE)--Key stakeholders in the diabetes industry convened in Washington D.C. on Sept. 28-29 for the AACE/ACE Consensus Conference on Glucose Monitoring to address current barriers to optimal diabetes care.

September 30, 2014

ACTON, Mass.--(BUSINESS WIRE)--Cognoptix raises over $15 million to fund pivotal clinical trial and final product development of eye test designed to identify early-stage Alzheimer’s Disease

September 30, 2014

BERKELEY HEIGHTS & PARSIPPANY, N.J.--(BUSINESS WIRE)--Edge Therapeutics, Inc. and Evonik Corporation announced that they have received a U.S. Patent expiring July 2033 covering EG-1962, Edge’s lead product candidate.

September 30, 2014

BARCELONA, Spain--(BUSINESS WIRE)--GE Healthcare is highlighting its industry leading credentials and new innovations in Intensive Care Medicine at the European Society of Intensive Care Medicine (ESICM) annual congress in Barcelona this week....

September 30, 2014

WARSAW, Ind.--(BUSINESS WIRE)--Biomet, Inc. announced today that in conjunction with its Fiscal 2015 First Quarter release, you are invited to participate in the conference call on Thursday, October 9, 2014 at 9:00 a.m. Eastern. Individuals...

September 30, 2014

NEWTOWN, Pa.--(BUSINESS WIRE)--Helius Medical Technologies, Inc. (CSE:HSM) is pleased to announce that it has completed the Commercial Design Specification phase of its commercial version of the Portable Neuromodulation Stimulator

September 30, 2014

HOUSTON--(BUSINESS WIRE)--Bio-Path Holdings, Inc., (NASDAQ:BPTH) (“Bio-Path”), a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced that Peter Nielsen, President and Chief Executive...

September 30, 2014

SEATTLE--(BUSINESS WIRE)--LabConnect, LLC., a leading provider of central laboratory services to the biopharmaceutical industry, announces the release of its BioVisualization software platform.

September 30, 2014

NEW YORK--(BUSINESS WIRE)--Agilis Biotherapeutics, LLC, a synthetic biology-based company focused on developing DNA-based therapeutics for rare genetic diseases, announced today the addition of James E. Darnell, Jr., M.D., Vincent Astor Professor...

September 30, 2014

NEW GLOUCESTER, Maine--(BUSINESS WIRE)--Manufacturers and clinical laboratories are doing a reasonably good job assessing endogenous interferents that may alter lab test results. The next big hurdle is the assessment of interference from common...

September 30, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist to Present New Data on Antibiotics Portfolio at IDWeek 2014

September 30, 2014

KNOXVILLE, Tenn.--(BUSINESS WIRE)--EDP Biotech Corporation, (“EDP,” or the “Company”), a global in vitro diagnostic innovator of life-saving, easy-to-use cancer diagnostic tests using ELISA technology, has announced CE Mark approval for...

September 30, 2014

FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. will host a webcast and conference call at 8:30 a.m. (EST) on Tuesday, Nov. 4, 2014 to review third quarter financial results.

September 30, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nimbus Discovery Appoints former Merck Executive Don Nicholson as CEO

September 30, 2014

EXTON, Pa.--(BUSINESS WIRE)--Fibrocell Science, Inc., (NASDAQ:FCSC), an autologous cell therapy company focused on developing first-in-class treatments for rare and serious skin and connective tissue diseases with high unmet medical needs, today...

September 30, 2014

REDWOOD CITY, Calif.--(BUSINESS WIRE)--PaxVax, Inc., a specialty vaccine company focused on travel and biodefense, today announced that company Chief Executive Officer Ken Kelley will be presenting at the 13th Annual BIO Investor Forum. Hosted by...

September 30, 2014

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--NephroGenex, Inc. (NASDAQ:NRX), a pharmaceutical company focused on the development of therapeutics to treat kidney disease, today announced that Pierre Legault, Chief Executive Officer, will present...

September 30, 2014

SAN DIEGO & VANCOUVER, British Columbia--(BUSINESS WIRE)--Sophiris Bio Inc., a biopharmaceutical company developing PRX302 for the treatment of the symptoms of benign prostatic hyperplasia (BPH, enlarged prostate), will be presenting at BIO...

September 30, 2014

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Quintiles Transnational Holdings Inc. (NYSE: Q) will release its third-quarter 2014 financial results Thursday, October 30, 2014 prior to its quarterly earnings call at 8:00 a.m. EDT.

September 30, 2014

MIDDLEBURG HEIGHTS, Ohio--(BUSINESS WIRE)--Reliable Skilled Care and Rehabilitation providing comprehensive pre-and post-surgical rehabilitation. Pre-surgical screening enhances speed and efficacy of recuperation and improves surgery outcome.

September 30, 2014

ELYRIA, Ohio--(BUSINESS WIRE)--Invacare Corporation announces amendment to credit agreement.

September 30, 2014

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Expands Management Team with Appointment of Susan Boynton as Vice President Global Regulatory Affairs

September 30, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a developer of innovative RNA-based therapeutics, today announced favorable safety results from the single ascending dose portion of a Phase I study of AVI-7100, the...

September 30, 2014

DUBLIN, Ireland--(BUSINESS WIRE)--Covidien announced today results from a recent online awareness survey highlighting the need for greater awareness of PAD.

September 30, 2014

GÖTEBORG, Sweden & RADNOR, Pa.--(BUSINESS WIRE)--Cortendo AB [ticker: CORT on NOTC-A], a biopharmaceutical company developing and commercializing products at the intersection of orphan diseases and endocrinology disorders, today announced ...

September 30, 2014

SAN DIEGO--(BUSINESS WIRE)--OncoSec Medical Announces October Events Agenda

September 30, 2014

LAUSANNE, Switzerland & LONDON--(BUSINESS WIRE)--ADC Therapeutics today announced a significant expansion of its team as the Company’s first ADCs enter clinical development.

September 30, 2014

MOSCOW & SAINT-LAURENT-DU-VAR, France--(BUSINESS WIRE)--NovaMedica LLC, a Russian pharmaceutical company, and Horus Pharma SL, a French company dedicated to the development of innovative products treating ophthalmic diseases, have signed a...

September 30, 2014

GRONINGEN, Netherlands--(BUSINESS WIRE)--Mucosis B.V., a clinical stage biotechnology company developing novel vaccines for infectious diseases, will present updates on its research and development program at the Biotech in Europe Forum taking...

September 30, 2014

LINCOLN, Neb.--(BUSINESS WIRE)--Celerion, announces the expansion of ophthalmological services in our Belfast, Northern Ireland UK facility, by building on our successful relationship with Queen’s University in Belfast.

September 30, 2014

GARGRAVE, England--(BUSINESS WIRE)--WOUNDCHEK™ Laboratories appoints ApoFit Arzneimittelvertrieb GmbH as exclusive distributor in Germany for the world’s first point of care diagnostic for chronic wound care.

September 30, 2014

LEIDEN, Netherlands--(BUSINESS WIRE)--to-BBB Completes Management Team and Announces Company Name Change to BBB Therapeutics

September 30, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--Avedro Inc. resubmits New Drug Application (NDA) for riboflavin ophthalmic solution/KXL® System to U.S. Food and Drug Administration (FDA).

September 30, 2014

PRINCETON, N.J. & DEERFIELD, Ill.--(BUSINESS WIRE)--Otsuka and Lundbeck announced today that the FDA has approved a new formulation of Abilify Maintena® (aripiprazole) for extended-release injectable suspension for the treatment of...

September 29, 2014

RALEIGH, N.C. & TARRYTOWN, N.Y.--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) and Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) today announced that the Food and Drug Administration has approved RELISTOR® (methylnaltrexone...

September 29, 2014

AUSTIN, Texas--(BUSINESS WIRE)--Astrotech Corporation (NASDAQ: ASTC), a leading provider of commercial aerospace services and products and a manufacturer of next generation chemical detection instrumentation, today announced financial results for...

September 29, 2014

NEW YORK--(BUSINESS WIRE)--NEMARIS, Inc. today announced the company has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the next-generation SURGIMAP 2.0 platform, the preeminent software used to preoperatively plan...